CLINICAL_TRIALS
trial_result
· 2018-08-21
Clinical Trial Update: 4% Chlorhexidine Gluconate Daily Bathing for Prevention of Hospital-acquired Infections in Intensive Care Settings [Phase 4]
Summary
Phase 4 trial evaluating daily bathing with 4% chlorhexidine gluconate to prevent hospital-acquired infections in intensive care settings has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Of Perugia | Conditions: Hospital Infection | Phase 4 | Status: COMPLETED